2018年3月24日星期六
2018年3月23日星期五
Dr. Haruki Kitazawa, Sendai, Japan
www.fcc.or.jp
<Screenshot_2018-03-22-10-28-13-94.png><Screenshot_2018-03-22-09-55-16-36.png>
<mmexport1521744881697.jpg><Screenshot_2018-03-22-20-34-43-12.png><Screenshot_2018-03-22-21-01-59-97.png><Screenshot_2018-03-22-21-02-28-17.png><Luo C et al ACAMC 2018.pdf><Luo C et al MMR 2017.pdf>
Mar 23 at 3:46 AM
Hi Cheng:
I remembered that I had met Mr. Leporanta in Valio, Dr. Ritta Korpela, Dr. Riina Kekkonen etc. with kind guidance from Dr. Fang He, Takahashi Milk company.
Please covey my best wishes to Mr. Leporanta. Anyway, hopefully we could get together in Helsinki 2019.
Best regards,
Haruki
2018/03/23 4:11、Cheng Luo <luo58@yahoo.com>のメール:Dear Haruki,Mr. Kalle Leporanta, the ex CTO of Valio said that he met you in June 2009 in Helsinki. I worked in Helsinki university in early 1990s, and Turku university 1990s - 2000s. I think we will be very happy to meet you in Helsinki 2019. Keep in touch.BR/Cheng<Screenshot_2018-03-22-21-01-59-97.png><Screenshot_2018-03-22-21-02-28-17.png><mmexport1521744881697.jpg><Screenshot_2018-03-22-20-34-43-12.png>
Hi Cheng:
I have been to Finland once. It was much impressive for me.
At that time, I visited Helsinki and Turku.
If I have a chance, I will come to Finland again before retirement.
One option, I have plan to attend FEMS2019 in Scotland. One the way back to Sendai, if possible,
I will stop by.
Anyway, all are depend on the future situations.
Best,
Haruki
2018/03/22 17:30、Cheng Luo <luo58@yahoo.com>のメール:Do you visit Finland sometime? Finland is popular tourist place for Japanese. I live in Helsinki, capital city of Finland. your city is well known for Sendai virus.<Screenshot_2018-03-22-10-28-13-94.png><Screenshot_2018-03-22-09-55-16-36.png>
Hi Cheng:
I never been to China.
I can not come to china in this term.
Sorry.
Best,
Haruki
2018/03/22 15:51、Cheng Luo <luo58@yahoo.com>のメール:Dear Dr. Kitazawa，I just wonder if you visit China sometime? I will be in China during April 1 -May 25.one professor in Baoding ( near Beijing) isstill working in viili.sincely yours,BR/Cheng
Dear Dr. Cheng:
Attached, please check our PDF reprint.
Best regards,
Haurki
On 2010/09/03, at 19:53, Cheng Luo wrote:
Dear Dr. Kitazawa,Thank you very much for informative message, and your excellent work. I think this is the best evidence so far to show that why viili and other probiotic bacteria are benefit to human. I wonder if you could send me a PDF, which indicated below.Thank you very much again!BR/Cheng====================================================================Molecular cloning of porcine RP105/MD-1 involved in recognition of extracellular phosphopolysaccharides from Lactococcus lactis ssp. cremorisReceived 24 August 2006;revised 15 November 2006;accepted 15 December 2006.Available online 24 January 2007.Abstract
In this study, we cloned the cDNAs encoding porcine RP105 (poRP105) and porcine MD-1 (poMD-1) from Peyer's patches of adult swine. The complete open reading frames of poRP105 and poMD-1 contain 1986 and 480 bp and encode 661 and 159 amino acid residues, respectively. These two proteins were more similar to the human (77.6% and 76.5% amino acid identity) than the mouse counterparts (70.0% and 71.1% amino acid identity). The results of several experiments in cells cotransfected with poRP105 and poMD-1 indicated both lipopolysaccharide and extracellular phosphopolysaccharide from Lactococcus lactis subsp. cremoris (Lc. cremoris) strongly activate nuclear factor-κB and induce the expression of various cytokines via RP105. These effects were mediated by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase. Thus, we identified extracellular polysaccharide from Lc. cremoris as an active substance that can induce immune activation via RP105 and MD-1.Keywords: RP105; MD-1; cDNA cloning; Swine; Extracellular phosphopolysaccharide; Lactococcus lactis subsp. cremoris; Immunobiotics
Dept. Biotechnology, University of Tartu, Riia St. 23, Tartu 51010, Estonia
Tel. +372 56731293 (Mobile), +372 7375085 (Office), Fax: +372 7420286,
Email: Cheng.Luo@ut.ee, http://www.biotech.ebc.ee/department_staff.htmNaulakalliontie 23 F 22, 00970, Helsinki, Finland, Tel. +358 50 3506158
https://www.etis.ee/portaal/isikuCV.aspx?lang=en&PersonVID=60154
http://www.google.com/profiles/updatepharmacy
====================================================================
From: 北澤 春樹 <haruki@bios.tohoku.ac.jp>
To: Cheng Luo <luo58@yahoo.com>
Cc: asosan@bios.tohoku.ac.jp
Sent: Fri, September 3, 2010 4:09:41 AM
Subject: Re: viili
Dear Dr. Cheng:Thanks for your e-mail.As you know, the finnish ropy sour milk Viili is produced by using ropy strainsof L. lactics subsp. cremoris. The ropy stain produce encapsulated phosphopolysaccharideresult in increasing viscosity under the existence of milk proteins.We found that certain receptors for the phosphopolysaccharide were Radio Protective-105and Toll-like receptor 4/MD2.Natou contains polyglutamic acid and Fructan. In generally, main factors for exhibitinghigh viscosity are thought to be the both substances.Well, if you are more interested in our research works, please check our published works.Again, thanks for your contact.Best regards,*************************************************Haruki Kitazawa, Ph.D. (Associate Professor)Food Immunology GroupGraduate School of Agricultural Science1-1 Tsutsumidori-Amamiyamachi, AobakuSendai, 981-8555, JapanTel:+81-22-717-8713, Fax:+81-22-717-8715E-mail:haruki@bios.tohoku.ac.jp*************************************************On 2010/09/01, at 19:31, Cheng Luo wrote:Dear Dr. Kitazawa,Could you like to comment a little about viili and Natou? since I understood that you have studied Finnish viili, and Natou is originally from Japan, but both are sticky because of rich in polysaccharidesThank you very much!Sincerely yours,BR/Cheng====================================================================
Dept. Biotechnology, University of Tartu, Riia St. 23, Tartu 51010, Estonia
Tel. +372 56731293 (Mobile), +372 7375085 (Office), Fax: +372 7420286,
Email: Cheng.Luo@ut.ee, http://www.biotech.ebc.ee/department_staff.htmNaulakalliontie 23 F 22, 00970, Helsinki, Finland, Tel. +358 50 3506158
https://www.etis.ee/portaal/isikuCV.aspx?lang=en&PersonVID=60154
http://www.google.com/profiles/updatepharmacy
====================================================================
订阅：
博文 (Atom)
